Advisor Group Holdings, Inc. Galectin Therapeutics Inc Call Options Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GALT
# of Institutions
95Shares Held
11.2MCall Options Held
134KPut Options Held
353K-
Vanguard Group Inc Valley Forge, PA2.18MShares$9.28 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$6.65 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY749KShares$3.18 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA666KShares$2.83 Million0.0% of portfolio
-
Wealthspire Advisors, LLC New York, NY480KShares$2.04 Million0.01% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $253M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...